Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
Main Authors: | Dashti-Khavidaki, S., Ghaffari, S., Gohari, M., Khatami, M. R., Zahiri, Z. |
---|---|
Format: | Online |
Language: | English |
Published: |
Avicenna Organ Transplantation Institute
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054140/ |
Similar Items
-
Clinical Pharmacokinetics of Tacrolimus in Iranian Liver Transplant Recipients
by: Nasiri-Toosi, Zahra, et al.
Published: (2014) -
Effectiveness of Intravenous Immunoglobulin Plus Plasmapheresis on Antibody-mediated Rejection or Thrombotic Microangiopathy in Iranian Kidney Transplant Recipient
by: Dashti-Khavidaki, Simin, et al.
Published: (2015) -
Genotype-guided tacrolimus dosing in African American kidney transplant recipients
by: Sanghavi, K., et al.
Published: (2015) -
Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
by: Lee, John R., et al.
Published: (2015) -
Coadministration of Liraglutide With Tacrolimus in Kidney Transplant Recipients: A Case Series
by: Pinelli, Nicole R., et al.
Published: (2013)